BackComera Life Sciences Holdings- Warrants (19/05/2027) Overview

Comera Life Sciences Holdings- Warrants (19/05/2027) Cost of Revenue

Cost of Revenue analysis for CMRAW.

Quarterly Cost of Revenue

$41961.00
31.17% YoY

As of Sep 30, 2023

Annual Cost of Revenue (TTM)

$264880.00
33.13% YoY

Trailing 12 months ending Sep 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)